The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
PRA HEALTH SCIENCES INC | COM | 69354M108 | 31,532 | 205,700 | SH | SOLE | 205,700 | 0 | 0 | ||
SLACK TECHNOLOGIES INC | COM CL A | 83088V102 | 484,932 | 11,935,315 | SH | SOLE | 11,935,315 | 0 | 0 | ||
WILLIS TOWERS WATSON PLC LTD | SHS | G96629103 | 411,239 | 1,796,745 | SH | SOLE | 1,796,745 | 0 | 0 | ||
AON PLC | SHS CL A | G0403H108 | 23 | 100 | SH | SOLE | 100 | 0 | 0 | ||
ALEXION PHARMACEUTICALS INC | COM | 015351109 | 621,128 | 4,064,176 | SH | SOLE | 4,064,176 | 0 | 0 |